Cary J. Claiborne

Chief Financial Officer, Osiris Therapeutics.

Companies

NeuroSense Therapeutics Ltd.Board member Mar 18, 2026 to now¹
ADIAL PHARMACEUTICALS, INC.Chief executive officer Aug 22, 2022 to now²
ADIAL PHARMACEUTICALS, INC.Board member Nov 3, 2021 to now³
CytRxBoard member Jul 28, 2022 to Jan 29, 2024⁴
ADIAL PHARMACEUTICALS, INC.Chief operating officer Dec 8, 2021 to Feb 25, 2022⁵
Sucampo PharmaceuticalsChief financial officer Oct 27, 2011 to Sep 15, 2014⁶
Osiris TherapeuticsChief financial officer Aug 3, 2006 to Nov 23, 2007⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NeuroSense Therapeutics Ltd. NRSN99,898 shares⁸$258.7K at $2.59Mar 18, 2026
ADIAL PHARMACEUTICALS, INC. ADIL40,417 shares⁹$147.9K at $3.66Apr 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 7, 2026Granted 37,985 shares of ADIAL PHARMACEUTICALS, INC.⁹
May 23, 2023Granted 420,000 shares of ADIAL PHARMACEUTICALS, INC.¹⁰
Sep 20, 2022Granted 75,000 shares at $0.42 of ADIAL PHARMACEUTICALS, INC.¹¹
Sep 19, 2022Granted 25,000 shares at $0.43 of ADIAL PHARMACEUTICALS, INC.¹¹
Aug 18, 2022Granted 1,000,000 shares of ADIAL PHARMACEUTICALS, INC.¹²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNeuroSense Therapeutics Ltd., Board member
2
SEC EDGARADIAL PHARMACEUTICALS, INC., Chief executive officer
3
SEC EDGARADIAL PHARMACEUTICALS, INC., Board member
4
SEC EDGARCytRx, Board member
5
SEC EDGARADIAL PHARMACEUTICALS, INC., Chief operating officer
6
SEC EDGARSucampo Pharmaceuticals, Chief financial officer
7
SEC EDGAROsiris Therapeutics, Chief financial officer
8
SEC EDGARNeuroSense Therapeutics Ltd. shares after the filing of Mar 18, 2026
9
SEC EDGARADIAL PHARMACEUTICALS, INC. shares after the filing of Apr 7, 2026
10
SEC EDGARForm 4 filed May 25, 2023
11
SEC EDGARForm 4 filed Sep 20, 2022
12
SEC EDGARForm 4 filed Aug 22, 2022